| Page 1375 | Kisaco Research
 

Anthony TA

Project Director & Innovation Watch Leader
Société Générale CIB

Anthony is leading the Blockchain, DLT and Privacy Enhancing Technologies innovation at SG.

He started as Pan European Equity Sales Trader in 2001 at SG Singapore and pursued his career with SG in the UK, Hong Kong, and France.

Since 2018, he joined the innovation department of SGCIB as a Project Director/Innovation & Watch Leader and is focusing on all technologies that enable, enhance and preserve data privacy throughout its lifecycle.

Read full bio

Anthony TA

Project Director & Innovation Watch Leader
Société Générale CIB

Anthony TA

Project Director & Innovation Watch Leader
Société Générale CIB

Anthony is leading the Blockchain, DLT and Privacy Enhancing Technologies innovation at SG.

He started as Pan European Equity Sales Trader in 2001 at SG Singapore and pursued his career with SG in the UK, Hong Kong, and France.

Since 2018, he joined the innovation department of SGCIB as a Project Director/Innovation & Watch Leader and is focusing on all technologies that enable, enhance and preserve data privacy throughout its lifecycle.

 

Niels Verhulst

Senior Researcher
University of Zürich

Niels acquired his PhD at Wageningen University, The Netherlands and is now a senior researcher at the University of Zürich leading a group of scientists working on the behavioural ecology of mosquitoes.  

He studies how skin microbial volatiles influence the attractiveness of humans and animals to mosquitoes. His goal is to develop novel skin bacterial based products that can reduce mosquito bites and thereby pathogen transmission.

Read full bio

Niels Verhulst

Senior Researcher
University of Zürich

Niels Verhulst

Senior Researcher
University of Zürich

Niels acquired his PhD at Wageningen University, The Netherlands and is now a senior researcher at the University of Zürich leading a group of scientists working on the behavioural ecology of mosquitoes.  

He studies how skin microbial volatiles influence the attractiveness of humans and animals to mosquitoes. His goal is to develop novel skin bacterial based products that can reduce mosquito bites and thereby pathogen transmission.

 

Melissa Sebok

Senior Director – Product Management, Direct Patient Care & Emerging Offerings
American Red Cross

Melissa Sebok

Senior Director – Product Management, Direct Patient Care & Emerging Offerings
American Red Cross

Melissa Sebok

Senior Director – Product Management, Direct Patient Care & Emerging Offerings
American Red Cross
Privacy-Enhancing Technology Summit 2022 Sponsorship Brochure
Q&A with Cytophage
 

Cara Eaton

Global Sustainability Director
Croda

Cara Eaton

Global Sustainability Director
Croda

Cara Eaton

Global Sustainability Director
Croda

Romain Daillère, Head of Preclinical Research, Co-Founder, Everimmune

Please introduce yourself and give a little background of your current activities?

My name is Romain Daillère, co-founder of EverImmune and acting as scientific director of the company, devoted to treating cancer patients with live biotherapeutic products for oral adjuvants to anticancer treatments.

 What is the most exciting areas of gut microbiome you are currently working on?

We are focusing on immuno-oncology. We are harnessing the potential of the gut microbiota for the development of diagnosis and therapeutic tools.

Romain Daillère, Head of Preclinical Research, Co-Founder, Everimmune

Please introduce yourself and give a little background of your current activities?

My name is Romain Daillère, co-founder of EverImmune and acting as scientific director of the company, devoted to treating cancer patients with live biotherapeutic products for oral adjuvants to anticancer treatments.

 What is the most exciting areas of gut microbiome you are currently working on?

We are focusing on immuno-oncology. We are harnessing the potential of the gut microbiota for the development of diagnosis and therapeutic tools.

Brice Le Françios, R&D Scientist At DNA Genotek

On July 6-7, Microbiome Connect brought together 250 industry experts, innovative researchers and clinical leaders in Amsterdam for the eighth annual Microbiome Connect: Europe. Across the two days, a key area of discussion focussed on gaining a more detailed picture of complex microbial communities. We sat down with Brice Le Francois, Senior R&D Manager, DNA Genotek to shed some light on the critical role of metatranscriptomics to characterise microbiome functionality.